Text-only version of this email
Sarepta Therapeutics, Inc.
11/26/24 A Form 8-K has been filed with the United States Securities and Exchange Commission.
View this filing →
Or click here to view all filings.
Show allNew Form 8-K for Sarepta Therapeutics, Inc.
Sarepta Therapeutics sent this email to their subscribers on November 29, 2024.
|
||||||||
|
||||||||
|
|